This Cooperative Agreement award from the National Cancer Institute's Cancer Biology Research program (CFDA 93.396) provides $877,856 to the H. Lee Moffitt Cancer Center and Research Institute to develop the "Galaxy for Cancer" (Galaxy-C) computational platform. The key objectives are to:
-
Extend the Galaxy-C platform with new datasets and workflows to enable emerging cancer research in areas like single-cell, spatial, and multimodal data analyses.
-
Expand Galaxy-C with machine learning tools and an intelligent user interface to better support cancer analyses requiring advanced computational capabilities.
-
Integrate and leverage external computing services within Galaxy-C to power larger-scale cancer data analyses in a cost-effective manner.
-
Grow a multi-institutional community of Galaxy-C users within the cancer research ecosystem, including collaborations with the NIH's Informatics Technology for Cancer Research (ITCR) program and the NCI Human Tumor Atlas Network (HTAN).
The overall goals are to make state-of-the-art computational cancer research more accessible to a broader range of cancer scientists, thereby maximizing the impact of cancer data science investments on improving patient outcomes.
Generated 3/4/25, 6:27 AM